Psychiatric emergencies: Pathology review

3,709views

Psychiatric emergencies: Pathology review

Pediatrics

Pediatrics

Approach to acid-base disorders: Clinical sciences
Approach to metabolic acidosis: Clinical sciences
Approach to metabolic alkalosis: Clinical sciences
Approach to respiratory acidosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Approach to hypernatremia (pediatrics): Clinical sciences
Approach to hypocalcemia (pediatrics): Clinical sciences
Approach to hypoglycemia (pediatrics): Clinical sciences
Approach to hyponatremia (pediatrics): Clinical sciences
Adrenal insufficiency: Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Adnexal torsion: Clinical sciences
Appendicitis: Clinical sciences
Approach to abdominal wall and groin masses: Clinical sciences
Approach to dysmenorrhea: Clinical sciences
Cholecystitis: Clinical sciences
Ectopic pregnancy: Clinical sciences
Henoch-Schonlein purpura: Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Intussusception: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences
Urinary tract infection (pediatrics): Clinical sciences
Approach to anemia (destruction and sequestration): Clinical sciences
Approach to anemia (underproduction): Clinical sciences
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Approach to leukemia: Clinical sciences
Iron deficiency and iron deficiency anemia (pediatrics): Clinical sciences
Sickle cell disease: Clinical sciences
Approach to bleeding disorders (platelet dysfunction): Clinical sciences
Approach to bleeding disorders (thrombocytopenia): Clinical sciences
Immune thrombocytopenia: Clinical sciences
Meningitis (pediatrics): Clinical sciences
Sepsis (pediatrics): Clinical sciences
Celiac disease: Clinical sciences
Asthma: Clinical sciences
Bronchiolitis: Clinical sciences
Congestive heart failure: Clinical sciences
COVID-19: Clinical sciences
Croup and epiglottitis: Clinical sciences
Cystic fibrosis and primary ciliary dyskinesia: Clinical sciences
Influenza: Clinical sciences
Pneumonia (pediatrics): Clinical sciences
Tuberculosis (pulmonary): Clinical sciences
Upper respiratory tract infections: Clinical sciences
Clostridioides difficile infection: Clinical sciences
Approach to a fever (over 2 months): Clinical sciences
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Osteomyelitis (pediatrics): Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Septic arthritis and transient synovitis (pediatrics): Clinical sciences
Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Approach to bacterial causes of fever and rash (pediatrics): Clinical sciences
Acute group A streptococcal infections and sequelae (pediatrics): Clinical sciences
Approach to congenital infections: Clinical sciences
Juvenile idiopathic arthritis: Clinical sciences
Kawasaki disease: Clinical sciences
Lyme disease: Clinical sciences
Periorbital and orbital cellulitis (pediatrics): Clinical sciences
Toxic shock syndrome: Clinical sciences
Staphylococcal scalded skin syndrome and impetigo: Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Approach to congenital heart diseases (acyanotic): Clinical sciences
Approach to congenital heart diseases (cyanotic): Clinical sciences
Hypertrophic cardiomyopathy: Clinical sciences
Approach to hepatic masses: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Approach to a limp (pediatrics): Clinical sciences
Approach to a suspected bone tumor (pediatrics): Clinical sciences
Developmental dysplasia of the hip: Clinical sciences
Legg-Calve-Perthes disease and slipped capital femoral epiphysis: Clinical sciences
Approach to peripheral lymphadenopathy (pediatrics): Clinical sciences
Approach to a red eye: Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Acetaminophen (Paracetamol) toxicity: Clinical sciences
Approach to recreational substance exposure (pediatrics): Clinical sciences
Diabetes mellitus (pediatrics): Clinical sciences
Large bowel obstruction: Clinical sciences
Pyloric stenosis: Clinical sciences
Small bowel obstruction: Clinical sciences
Approach to a fever (0-60 days): Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Non-accidental trauma and neglect (pediatrics): Clinical sciences
Necrotizing enterocolitis: Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Approach to respiratory distress (newborn): Clinical sciences
Approach to cyanosis (newborn): Clinical sciences
Approach to shock (pediatrics): Clinical sciences
Approach to lower airway obstruction (pediatrics): Clinical sciences
Approach to upper airway obstruction (pediatrics): Clinical sciences
Anaphylaxis: Clinical sciences
Foreign body aspiration and ingestion (pediatrics): Clinical sciences
Approach to a first unprovoked seizure (pediatrics): Clinical sciences
Febrile seizure (pediatrics): Clinical sciences
Approach to bradycardia: Clinical sciences
Approach to tachycardia: Clinical sciences
Brief, resolved, unexplained event (BRUE): Clinical sciences
Approach to hematochezia (pediatrics): Clinical sciences
Burns: Clinical sciences
Neurogenic shock: Clinical sciences
Approach to delayed puberty: Clinical sciences
Approach to feeding and eating disorders: Clinical sciences
Approach to neurodevelopmental disorders: Clinical sciences
Approach to precocious puberty: Clinical sciences
Approach to short stature: Clinical sciences
Autism spectrum disorder: Clinical sciences
Approach to a child with Down syndrome (trisomy 21): Clinical sciences
Dyslipidemia: Clinical sciences
Essential hypertension: Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Developmental milestones (toddler): Clinical sciences
Developmental milestones (childhood): Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Immunizations (pediatrics): Clinical sciences
Well-child visit (adolescent): Clinical sciences
Well-child visit (newborn and infant): Clinical sciences
Well-child visit (toddler and child): Clinical sciences
Well-patient care (GYN): Clinical sciences
Sports physical (pediatrics): Clinical sciences
Antidiuretic hormone
Body fluid compartments
Movement of water between body compartments
Sodium homeostasis
Acid-base disturbances: Pathology review
Diabetes insipidus and SIADH: Pathology review
Electrolyte disturbances: Pathology review
Renal failure: Pathology review
Acyanotic congenital heart defects: Pathology review
Adrenal masses: Pathology review
Bacterial and viral skin infections: Pathology review
Bone tumors: Pathology review
Coagulation disorders: Pathology review
Congenital neurological disorders: Pathology review
Cyanotic congenital heart defects: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Headaches: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Leukemias: Pathology review
Lymphomas: Pathology review
Macrocytic anemia: Pathology review
Microcytic anemia: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Pediatric brain tumors: Pathology review
Pediatric musculoskeletal disorders: Pathology review
Platelet disorders: Pathology review
Renal and urinary tract masses: Pathology review
Seizures: Pathology review
Viral exanthems of childhood: Pathology review
Adrenal insufficiency: Pathology review
Central nervous system infections: Pathology review
Childhood and early-onset psychological disorders: Pathology review
Congenital gastrointestinal disorders: Pathology review
Diabetes mellitus: Pathology review
Environmental and chemical toxicities: Pathology review
Gastrointestinal bleeding: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Inflammatory bowel disease: Pathology review
Medication overdoses and toxicities: Pathology review
Obstructive lung diseases: Pathology review
Pneumonia: Pathology review
Psychiatric emergencies: Pathology review
Shock: Pathology review
Supraventricular arrhythmias: Pathology review
Traumatic brain injury: Pathology review
Ventricular arrhythmias: Pathology review
Congenital TORCH infections: Pathology review
Jaundice: Pathology review
Respiratory distress syndrome: Pathology review
Autosomal trisomies: Pathology review
Cystic fibrosis: Pathology review
Disorders of sex chromosomes: Pathology review
HIV and AIDS: Pathology review
Miscellaneous genetic disorders: Pathology review
Papulosquamous and inflammatory skin disorders: Pathology review
Anxiety disorders, phobias and stress-related disorders: Pathology Review
Developmental and learning disorders: Pathology review
Eating disorders: Pathology review
Mood disorders: Pathology review
Breastfeeding
Pharmacodynamics: Agonist, partial agonist and antagonist
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Drug-receptor interactions
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug metabolism
Androgens and antiandrogens
Estrogens and antiestrogens
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Antihistamines for allergies
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
DNA synthesis inhibitors: Metronidazole
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Aminoglycosides
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Glucocorticoids
Azoles
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants

Transcript

Watch video only

A 53 year old male named Noah is brought to the emergency department by his son, who found him with an empty bottle of fluoxetine in his hand. His son mentions that Noah was recently diagnosed with depressive disorder. Upon physical examination, you realize that Noah has a body temperature of 38.9 degrees Celsius, or 102.02 degrees Fahrenheit, and a blood pressure of 162 over 95 millimeters of mercury. In addition, Noah’s pupils appear dilated, and his muscles are very stiff. Finally, neurological examination reveals that Noah has overactive reflexes. Later that day, a 34 year old female named Amelia is brought to the emergency department by her husband. He explains that Amelia has a medical history of schizophrenia, and a few days back she took multiple doses of haloperidol. Upon physical examination, Amelia’s body temperature is 38.7 degrees Celsius or 101.66 degrees Fahrenheit, and her blood pressure is 170 over 100 millimeters of mercury. Similarly to Noah, Amelia has muscle stiffness, but neurological examination reveals diminished reflexes.

All right, now, both Noah and Amelia seem to have some form of psychiatric emergency, which is when a psychiatric condition becomes life-threatening and requires prompt treatment. For your exams, some high yield psychiatric emergencies include suicide attempts, serotonin syndrome, acute dystonia, neuroleptic malignant syndrome, tyramine-induced hypertensive crisis, and delirium tremens.

Now, a very relevant psychiatric emergency, not only for your exams, are suicide attempts. Suicide is when someone takes their own life intentionally. Now, many suicide attempts can be prevented by keeping an eye out for red flags or risk factors, which can be easily remembered with the memory trick SAD PERSONS. The first S here stands for sex, as suicide tends to be more common among males. Next, A stands for age, so remember that suicide is more common among young adults and the elderly. For your exams, you should know that suicide is the second leading cause of death among individuals aged 15 to 34 in the USA, behind motor vehicle crashes. D is for depressive disorder, which is a psychiatric disorder that causes a persistent feeling of sadness, associated with a loss of interest in everyday activities like hobbies. Then P stands for previous suicide attempts, which remember is the most important risk factor for suicide. E stands for excessive alcohol or substance abuse, which causes individuals to be more impulsive, taking risks they normally wouldn’t take like driving recklessly. Oftentimes, alcohol or substance abuse occur together with depression. In fact, many people who experience depression turn to alcohol or substances to temporarily numb their feelings. And vice versa, chronic alcohol or substance abuse can ultimately cause depression, creating a vicious cycle. R is for rational thinking loss in psychosis, a severe mental disorder that can impair thought and emotions, to the point where individuals lose touch with reality. The next S is for sickness, which refers to chronic nonpsychiatric diseases, like end-stage cancer, that can be very hard to deal with. O stands for organized plan, which is when the individual has a specific method for suicide in mind. What’s very important to remember is that the most common method involves firearms like guns. For that reason, it’s key to evaluate if the individual has access to firearms. Next, N stands for no social support, meaning that they have no friends or family to turn to during vulnerable times. The last S refers to stated future intent, which is when a person expresses their suicidal thoughts or intentions.

Now, even if there are no risk factors for suicide, some people may impulsively take their lives in a moment of overwhelming life stress. This could be due to the loss of a loved one, going through a financial crisis, or experiencing various social pressures. Because of that, it’s just as important to focus on protective factors that can reduce the potential for suicidal behavior. Protective factors can include helping individuals develop self-esteem and coping skills. In addition, having cultural and religious beliefs, as well as a sense of purpose in life can discourage suicide. Finally, a key protective factor is companionship and emotional support.

If you suspect that someone’s at risk for attempting suicide, the first thing you should do is evaluate how serious the threat is, and suggest that they seek for help or be hospitalized voluntarily. If they refuse to get help, and they’re an imminent threat, they should be hospitalized involuntarily.

The next high yield psychiatric emergency is serotonin syndrome. Now, serotonin, also called 5-hydroxytryptamine or 5-HT for short, is a neurotransmitter that mainly helps regulate mood and emotions. Presynaptic serotonergic neurons synthesize serotonin and store it in small vesicles. When an action potential reaches the presynaptic membrane, the vesicles fuse with the membrane and release the serotonin into the synaptic cleft. The free serotonin then binds to serotonin or 5HT receptors on the postsynaptic neuron, causing it to fire off its own action potential. The presynaptic membrane also has serotonin reuptake transporters or SERTs, which take serotonin back into the presynaptic neuron, so the postsynaptic neuron stops firing. Inside the presynaptic neuron, some of this serotonin is packed into pre-existing vesicles, waiting to be released once more, while the rest of the serotonin is broken down by mitochondrial enzymes called monoamine oxidases or MAOs for short.

Okay, now, serotonin syndrome is a potentially life-threatening condition caused by high levels of serotonin in the brain. For your tests, remember that most cases of serotonin syndrome occur in people taking psychiatric medications to treat depression, which can be classified as typical and atypical antidepressants. Typical antidepressants include medications that block serotonin reuptake transporters, such as selective serotonin reuptake inhibitors or SSRIs like fluoxetine, serotonin norepinephrine reuptake inhibitors or SNRIs like duloxetine, and tricyclic antidepressants or TCAs like amitriptyline. Typical antidepressants also include medications called monoamine oxidase inhibitors or MAOIs for short, which inhibit the breakdown of serotonin by monoamine oxidases. What’s very high yield is that serotonin syndrome is most likely to occur when MAOIs are taken in combination with another antidepressant medication! Now, some atypical antidepressants, such as vilazodone and vortioxetine, can also cause serotonin syndrome by blocking serotonin reuptake inhibitors. Another important psychiatric medication that can cause serotonin syndrome is buspirone, which is mainly used to treat anxiety disorders. What buspirone does is it binds to serotonin receptors on the postsynaptic membrane and activates them, thereby potentiating the effect of serotonin in the central nervous system.

Now, it’s important to note that serotonin syndrome can also be caused by some nonpsychiatric medications, which you can remember using the mnemonic: The LOSt MD Took MDMA - Tramadol, Linezolid, Ondansetron, St. John’s wort, Meperidine, Dextromethorphan, Triptans, and MDMA. Okay, so tramadol, meperidine, dextromethorphan, and St. John’s wort, all increase the concentration of serotonin by blocking serotonin reuptake transporters. Another medication you should think of is linezolid, which blocks monoamine oxidases and prevents them from breaking down serotonin. Next we have ondansetron, which acts as a serotonin receptor antagonist, which means that it binds and inhibits serotonin receptors on the postsynaptic membrane. As a result, serotonin can’t bind to its receptors, so it builds up throughout the central nervous system. On the flip side, triptans act as serotonin receptor agonists, so they bind and activate serotonin receptors. Finally, MDMA stimulates the presynaptic neurons to release serotonin.

Okay, to remember the most common clinical features of serotonin syndrome, think of the 3 A’s, which are autonomic effects, abnormal neuromuscular activity, and altered mental status. Autonomic effects can include gastrointestinal disturbances like diarrhea, diaphoresis or excessive sweating, mydriasis or dilated pupils, and hyperthermia or increased body temperature, as well as hypertension or elevated blood pressure, and tachycardia or increased heart rate. Abnormal neuromuscular activity may manifest as myoclonus or muscle twitching, hyperreflexia or excessive reflexes, hypertonia or increased muscle tone, tremor or involuntary shaking, and even seizures. Finally, altered mental status may present with agitation, confusion, hallucinations, or even coma.

Treatment of serotonin syndrome involves the administration of benzodiazepines and supportive care, and in severe cases administration of cyproheptadine, which can inhibit serotonin receptors.

Now, another very similar psychiatric emergency is neuroleptic malignant syndrome. Now, the exact mechanism behind neuroleptic malignant syndrome is unclear, but it seems to be associated with dopamine receptor blockade. In fact, it typically occurs in individuals taking antipsychotic medications, which remember is often used to treat schizophrenia. Most cases are caused by typical antipsychotic medications, such as haloperidol. Now, typical antipsychotics work by blocking dopamine D2 receptors, which are found in various pathways within the brain. Some high yield pathways include the mesolimbic pathway, which controls feelings of motivation, reward, and desire; the mesocortical pathway, which helps regulate emotions; and the nigrostriatal pathway, which helps control involuntary movements and coordination. Less frequently, neuroleptic malignant syndrome may be caused by atypical antipsychotics like clozapine, which can block both dopamine D2 receptors and serotonin receptors. What’s really important to note is that medications are usually not enough to develop neuroleptic malignant syndrome. In fact, there seems to be a genetic predisposition in those who have genetic variations in the gene that codes dopamine D2 receptors. And that’s a high yield fact!

Symptoms of neuroleptic malignant syndrome typically start days to weeks after starting the medications. To help you recall the most high yield symptoms, think of FEVER. F actually stands for fever or hyperthermia, and it’s one of the most characteristic symptoms of neuroleptic malignant syndrome. The first E stands for encephalopathy or brain dysfunction, which presents with an altered mental status that can range from confusion or delirium to coma. Then there’s V for vitals, which are typically unstable. This means that individuals with neuroleptic malignant syndrome may experience tachycardia, as well as a labile blood pressure that may suddenly go from normal to really high levels. Now, unstable vitals can often be associated with diaphoresis, and that’s a very high yield fact! Okay, the second E stands for enzymes, such as creatine kinase that may be elevated in blood, as well as myoglobinuria or the presence of myoglobin in urine. What’s important to note here is that these enzymes are normally found inside skeletal muscle cells, so finding them around in blood or urine typically indicates rhabdomyolysis or abnormal skeletal muscle breakdown. And what's even more important is that these enzymes can be harmful to the kidneys and often lead to acute renal failure. Finally, R stands for rigidity of muscles, which is characterized by an increased muscle tone that causes constant resistance when another person tries to move the joint of the affected individual. In a test question, this may be referred to as “lead pipe” rigidity.

Now, some of these symptoms may trick you into thinking of serotonin syndrome, so to set these two apart, remember that neuroleptic malignant syndrome tends to cause more severe hyperthermia and muscle rigidity. In addition, individuals with serotonin syndrome typically also experience mydriasis, hyperreflexia, myoclonus, and diarrhea. So be sure to keep an eye out for these clues!

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "Diagnostic and Statistical Manual of Mental Disorders" NA (1980)
  5. "Suicide prevention strategies revisited: 10-year systematic review" The Lancet Psychiatry (2016)
  6. "Psychiatric Emergencies in the Intensive Care Unit" AACN Advanced Critical Care (2015)
  7. "Neuroleptic Malignant Syndrome" American Journal of Psychiatry (2007)